Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use XDEMVY safely and effectively. See full prescribing information for XDEMVY. XDEMVY™ (lotilaner ophthalmic solution) 0.25%, for topical ophthalmic use Initial U.S. Approval: 2023
Medication labelWhy this: Advisory · dailymed-prescription
XDEMVY is indicated for the treatment of Demodex blepharitis.
- generic_name
- lotilaner ophthalmic solution
- product_names
- Lotilaner ophthalmic solution
- ndc
- 81942-125, 81942-125-01, 81942-125-99
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en